A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation – JOELLE study)

MLA

Castellsague J, et al. “A Cohort Study on the Risk of Lymphoma and Skin Cancer in Users of Topical Tacrolimus, Pimecrolimus, and Corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation – JOELLE Study).” Clinical Epidemiology, vol. ume 10, Mar. 2018, pp. 299–310. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.2027abbb85ed4debba7b7d56e2e194c1&authtype=sso&custid=ns315887.

APA

Castellsague J, Kuiper JG, Pottegård A, Anveden Berglind I, Dedman D, Gutierrez L, Calingaert B, van Herk-Sukel MP, Hallas J, Sundström A, Gallagher AM, Kaye JA, Pardo C, Rothman KJ, & Perez-Gutthann S. (2018). A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation – JOELLE study). Clinical Epidemiology, ume 10, 299–310.

Chicago

Castellsague J, Kuiper JG, Pottegård A, Anveden Berglind I, Dedman D, Gutierrez L, Calingaert B, et al. 2018. “A Cohort Study on the Risk of Lymphoma and Skin Cancer in Users of Topical Tacrolimus, Pimecrolimus, and Corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation – JOELLE Study).” Clinical Epidemiology ume 10 (March): 299–310. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.2027abbb85ed4debba7b7d56e2e194c1&authtype=sso&custid=ns315887.